The embodiments disclosed herein relate to distal tip for systems for use during an bone fixation procedure and methods of their use.
Fracture repair is the process of rejoining and realigning the ends of broken bones. Currently there are several internal approaches to repair, strengthen and support a fractured bone. Conventional internal fixation devices include wires, plates, rods, pins, nails, and screws to support the fractured bone directly, as well as the addition of reinforcing materials to the fractured bone. Newer internal fixation devices include expandable members that can be expanded with curable material and hardened inside the intramedullary cavity of a bone to provide a conformal fit inside the intramedullary cavity, which leads to greater support and strength to the healing bone. However, there is still a need for further improvements of such internal fixation devices.
Distal tip designs for bone fixation devices are disclosed. According to some aspects illustrated herein, there is provided a device for bone fixation that includes a delivery catheter comprising an outer tube and an inner tube disposed within the outer tube and extending beyond the outer tube; an expandable member having a proximal region and a distal region, the expandable member being releasably attached about a distal end of the delivery catheter at the proximal region of the expandable member, and a distal cap attached to the distal region of the expandable member to seal the expandable member; and an inner compartment in the distal region of the expandable member, the inner tube and enable movement of the inner tube within the inner compartment.
According to some aspects illustrated herein, there is provided a system for bone fixation that includes a delivery catheter having a proximal end and a distal end; an expandable member having a proximal region and a distal region, wherein the expandable member is releasably attached about the distal end of the delivery catheter at the proximal region of the expandable member; a distal cap attached to the distal region of the expandable member to seal the expandable member; a light conducting fiber; and a light-sensitive liquid; wherein the delivery catheter has an inner void for passage of a light-sensitive liquid into the expandable member to expand the expandable member and an inner lumen for passage of the light conducting fiber into the expandable member to cure the light-sensitive liquid inside the expandable member.
According to some aspects illustrated herein, there is provided a method for bone fixation that includes advancing to a fractured bone a device comprising a delivery catheter having a proximal end and a distal end; an expandable member having a proximal region and a distal region, wherein the expandable member is attached about the distal end of the delivery catheter at the proximal region of the expandable member; and a distal cap attached to the distal region of the expandable member to seal the expandable member; positioning the expandable member within an intramedullary cavity of the fractured bone; expanding the expandable member with a light-sensitive liquid; and curing the light-sensitive liquid within the expandable member.
The presently disclosed embodiments will be further explained with reference to the attached drawings, wherein like structures are referred to by like numerals throughout the several views. The drawings shown are not necessarily to scale, with emphasis instead generally being placed upon illustrating the principles of the presently disclosed embodiments.
While the above-identified drawings set forth presently disclosed embodiments, other embodiments are also contemplated, as noted in the discussion. This disclosure presents illustrative embodiments by way of representation and not limitation. Numerous other modifications and embodiments can be devised by those skilled in the art which fall within the scope and spirit of the principles of the presently disclosed embodiments.
Systems and methods for bone fixation procedures are disclosed herein. In some embodiments, distal tip designs for internal bone fixation devices are disclosed.
In some embodiments, the expandable member 200 is manufactured from a thin-walled, non-compliant (non-stretch/non-expansion) conformable material. The expandable member 200 may be formed of a pliable, resilient, conformable, and strong material, including but not limited to urethane, polyethylene terephthalate (PET), nylon elastomer and other similar polymers. In some embodiments, the expandable member 200 of the present disclosure is constructed out of a PET nylon aramid or other non-consumable materials. The expandable member 200 may be impregnated with a radiopaque material to enhance the visibility of the expandable member 200. The expandable member 200 is biocompatible, thus preventing or reducing possible adverse reactions after insertion into a fractured bone. In some embodiments, the expandable member 200 is made from a material that is non-toxic, non-antigenic and non-immunogenic.
The expandable member 200 includes a proximal area 212 and a distal area 214. The proximal area 212 of the expandable member 200 is releasably connected to the delivery catheter 101. The distal area 214 may be connected to the delivery catheter 101 in a variety of ways.
In reference to
In some embodiments, the distal cap 300 may be formed, molded or machined from an implant grade polymer (e.g., PET), or another biocompatible material. The distal cap 300 may also be made from a filled material. For example, the PET polymer may be blended with a radiopaque material (e.g., barium sulfate, tungsten, tantalum, etc.) such that the distal cap 300 may be viewed with the assistance of fluoroscopic imaging. In some embodiments, the distal cap 300 may also be covered with a reflective material such as a gold film (or other metallic highly polished implant grade film) to enable the distal cap 300 to reflect light radiating from the end of the light pipe back into the balloon. This reflected light can help to reduce the cure time of the light sensitive liquid contained within the expandable member 200 to due to the increase in light energy directed at the light sensitive liquid. In some embodiments, the distal cap 300 may also be fabricated from a crystalline material (such as crystalline PET) to block the transmission of light through the end of the device 100 and to reflect and/or scatter the light back to the light sensitive liquid in the expandable member 200.
As illustrated in
While the central tube 220 may be free floating, in some embodiments, the central tube 220 may also be tethered to the distal cap by means of a filament or fiber to prevent the central tube 220 from becoming completely dislodged from within the distal cap 300. The filament or fiber may be elastic or rigid under tension and compression. In some embodiments, the central tube 220 may be rigidly secured to the distal cap 300. The central tube 220 may be secured inside the compartment 303 by press fitting the central tube 220 into the compartment 303; applying permanent adhesive on the surfaces between the central tube 220 and the compartment 303; melt bonding the two surfaces together or other techniques.
The distal end 306 of the body 302 may be either open or closed. In some embodiments, the distal cap 300 closes the distal tip 306 of the body 302 to close the distal tip 306. The distal cap 300 includes an inner surface 309, which faces the body 302, and an outer surface 310, which faces away from the body 302. In some embodiments, the outer surface 310 of the distal cap 300 may be rounded or smooth to provide the device 100 with an atraumatic distal point. In some embodiments, the distal cap 300 may have a semi-circular shape with a flat inner surface and a curved outer surface. In some embodiments, the body 302 may be open as long as there is a seal created, such as by for example, sealing the central tube 220 to the inner surface of the inner compartment 303 to prevent movement of fluids in and out of the expandable member 200.
In reference to
In reference to
In reference to
In some embodiments, the central tube 220 may be sealed distally by a melt 221 formed by a process such as an RF heated mold (as shown in
In reference to
In reference to
Light-sensitive liquid can be introduced into the proximal end 112 of the delivery catheter 101 and passes through the inner void 210 of the delivery catheter 101 up into the inner cavity 235 of the expandable member 200 to move the expandable member from a deflated state to an inflated state when the light-sensitive liquid is delivered to the expandable member, in order to form a rigid orthopedic stabilizer. In some embodiments, the light-sensitive liquid is provided as a unit dose. As used herein, the term “unit dose” is intended to mean an effective amount of light sensitive liquid adequate for a single session. By way of example, a unit dose of a light sensitive liquid of the present disclosure for expanding an expandable member of the present disclosure may be defined as enough light-sensitive liquid to expand the expandable member so that the expanded expandable member realigns a fractured bone and/or secures the bone back into an anatomical position. The amount of realigning may vary somewhat from user to user. Thus, a user using a unit dose may have excess light-sensitive liquid left over. It is desirable to provide enough light-sensitive liquid that even the above-average user will have an effective amount of realignment. In some embodiments, a unit dose of a light-sensitive liquid of the present disclosure is contained within a container. In some embodiments, a unit dose of a light-sensitive liquid of the present disclosure is contained in an ampoule. In some embodiments, the expandable member is sufficiently shaped to fit within a space or a gap in a fractured bone. In some embodiments, the light-sensitive liquid can be delivered under low pressure via a standard syringe attached to the port 135. The light-sensitive liquid can be aspirated and reinfused as necessary, allowing for adjustments to the expandable member. These properties allow a user to achieve maximum fracture reduction prior to activating a light source and converting the liquid monomer into a hard polymer.
A light-conducting fiber communicating light from the light source can be introduced into the proximal end 112 of the delivery catheter 101 through port 115 and passes within an inner lumen of the delivery catheter 101 up into the expandable member. In some embodiments, the light source emits frequency that corresponds to a band in the vicinity of 390 nm to 770 nm, the visible spectrum. In some embodiments, the light source emits frequency that corresponds to a band in the vicinity of 410 nm to 500 nm. In some embodiments, the light source emits frequency that corresponds to a band in the vicinity of 430 nm to 450 nm. The light-sensitive liquid remains a liquid monomer until activated by the light-conducting fiber (cures on demand). In some embodiments, the liquid monomer is exposed to an appropriate frequency of light and intensity to cure the monomer inside the expandable member and form a rigid structure. In some embodiments, the liquid monomer is exposed to electromagnetic spectrum that is visible (frequency that corresponds to a band in the vicinity of 390 nm to 770 nm). In some embodiments, the liquid monomer is radiolucent, which permit x-rays to pass through the liquid monomer. Radiant energy from the light source is absorbed and converted to chemical energy to quickly (e.g., cured in about five seconds to about 10 minutes) polymerize the monomer. This cure affixes the expandable member in an expanded shape. A cure may refer to any chemical, physical, and/or mechanical transformation that allows a composition to progress from a form (e.g., flowable form) that allows it to be delivered through the inner void in the delivery catheter 101, into a more permanent (e.g., cured) form for final use in vivo. For example, “curable” may refer to uncured composition, having the potential to be cured in vivo (as by catalysis or the application of a suitable energy source), as well as to a composition in the process of curing (e.g., a composition formed at the time of delivery by the concurrent mixing of a plurality of composition components).
Additives may be included in light-sensitive liquids, including, but not limited to, drugs (for example, antibiotics), proteins (for example, growth factors) or other natural or synthetic additives (for example, radiopaque or ultrasonically active materials). In some embodiments, the viscosity of the light-sensitive liquid has a viscosity of about 1000 cP or less. In some embodiments, the light-sensitive liquid has a viscosity ranging from about 650 cP to about 450 cP. The expandable member may be inflated, trial fit and adjusted as many times as a user wants with the light-sensitive liquid, up until the light source is activated, when the polymerization process is initiated. Because the light-sensitive liquid has a liquid consistency and is viscous, the light-sensitive liquid may be delivered using low pressure delivery and high pressure delivery is not required, but may be used.
In some embodiments, a contrast material may be added to the light-sensitive liquid without significantly increasing the viscosity. Contrast materials include, but are not limited to, bismouth subcarbonate, barium sulfate, bismuth subcarbonate, tantalum, or other contrast materials known in the art. The light-sensitive liquid can be introduced into the proximal end of the delivery catheter and passes within the inner void of the delivery catheter up into an inner cavity of the expandable member to change a thickness of the expandable member without changing a width or depth of the expandable member. In some embodiments, the light-sensitive liquid is delivered under low pressure via the syringe attached to the port. The light-sensitive liquid can be aspirated and reinfused as necessary, allowing for thickness adjustments to the expandable body prior to activating the light source and converting the liquid monomer into a hard polymer. Low viscosity allows filling of the intramedullary implant through a very small delivery system.
One or more radiopaque markers or bands may be placed at various locations along the expandable member 200 and/or the delivery catheter 101. A radiopaque ink bead may be placed at a distal end of the expandable member for alignment of the apparatus during fluoroscopy. The one or more radiopaque bands and radiopaque ink bead, using radiopaque materials such as bismouth subcarbonate, barium sulfate, tantalum, or other materials known to increase radiopacity, allows a medical professional to view the apparatus using fluoroscopy techniques. The one or more radiopaque bands also provide visibility during inflation of the expandable member to determine the precise positioning of the expandable member during placement and inflation.
In some embodiments, the expandable member 200 can have a length greater than about 300 mm and a diameter greater than about 20 mm. In such embodiments, there is the potential that during the curing of the light-sensitive liquid, a far distal area 214 of the expandable member 200 will exhibit a shrinkage upon cure of about 2 to about 3 percent, while a proximal area 212 of the expandable member 200 is being cured. In some embodiments, to prevent this from transpiring, the central tube 220 of the expandable member 200 can be pressurized by virtue of the infusion of either air or other fluids (saline, water) through port 125 at the proximal end 112 of the delivery catheter 101. The infusion will cause internal diameter pressure against the light-sensitive liquid contained within the inner cavity 235 of the expandable member 200 so that during the curing process, the pressure keeps the light-sensitive liquid pressurized, and up in contact with inner surface 230 of the expandable member 200. When the light-conducting fiber is inserted within the central tube 220 and the light-sensitive liquid is infused, the extra space is pressed down on the central tube 220. In some embodiments, the central tube 220 is rigid and heat resistant so it does not deform, collapse or expand, due to the light energy from the light conducting fiber to facilitate easy removal of the light conducting fiber after the cure cycle. In some embodiments, an expandable member of the present disclosure has a diameter ranging from about 4 mm to about 30 mm. In some embodiments, an expandable member of the present disclosure has a length ranging from about 20 mm to about 500 mm. An expandable member of the present disclosure may be round, flat, cylindrical, oval, rectangular or any desired shape for a given application. In some embodiments, an expandable member of the present disclosure has a diameter of about 4 mm and a length of about 30 mm. In some embodiments, an expandable member of the present disclosure has a diameter of about 5 mm and a length of about 40 mm. In some embodiments, an expandable member of the present disclosure has a diameter of about 6 mm and a length of about 30 mm. In some embodiments, an expandable member of the present disclosure has a diameter of about 6 mm and a length of about 40 mm. In some embodiments, an expandable member of the present disclosure has a diameter of about 6 mm and a length of about 50 mm. In some embodiments, an expandable member of the present disclosure has a diameter of about 7 mm and a length of about 30 mm. In some embodiments, an expandable member of the present disclosure has a diameter of about 7 mm and a length of about 40 mm. In some embodiments, an expandable member of the present disclosure has a diameter of about 4 mm to about 20 mm and a length of about 30 mm to about 280 mm.
In some embodiments, an outer surface of an expandable member of the present disclosure is resilient. In some embodiments, an outer surface of an expandable member of the present disclosure is substantially even and smooth. In some embodiments, an outer surface of an expandable member of the present disclosure is not entirely smooth and may have some small bumps or convexity/concavity along the length. In some embodiments, an outer surface of an expandable member of the present disclosure may have ribs, ridges, projections, bumps or other shapes. In some embodiments, the ribs, ridges, projections, bumps, or other shapes on the rough or uneven outer surface of the expandable member improve penetration of the at least one fastener into the expandable member. In some embodiments, the ribs, ridges, projections, bumps, or other shapes on the rough or uneven outer surface of the expandable member improve penetration of the at least one fastener into the expandable member anywhere along a length of the expandable member. In some embodiments, the ribs, ridges, projections, bumps, or other shapes on the rough or uneven outer surface of the expandable member increase friction between the outer surface of the expandable member and the at least one fastener so as to reduce slippage of the at least one fastener as the at least one fastener is driven towards the outer surface of the expandable member. In some embodiments, the ribs, ridges, projections, bumps, or other shapes on the rough or uneven outer surface of the expandable member interacts with a threaded portion of the at least one fastener so as to improve penetration and fastening of the at least one fastener into the expandable member. In some embodiments, the ribs, ridges, projections, bumps, or other shapes on the rough or uneven outer surface of the expandable member interact with a tip of the at least one fastener to improve the wedge ability of the tip of the fastener so as to decrease the driving force needed to penetrate the expandable member. In some embodiments, an outer surface of an expandable member of the present disclosure has an uneven geometry. In some embodiments, an outer surface of an expandable member of the present disclosure has a textured surface which provides one or more ridges that allow grabbing. In some embodiments, the one or more ridges on the textured surface of the expandable member allow grabbing of the at least one fastener so as to improve the penetration of the at least one fastener into the expandable member. In some embodiments, the one or more ridges on the textured surface of the expandable member allow grabbing of bone so as to improve adhesion between the expandable member and bone as regenerating bone grows onto the outer surface of the expandable member. In some embodiments, abrasively treating an outer surface of an expandable member of the present disclosure for example via chemical etching or air propelled abrasive media improves the connection and adhesion between the outer surface of the expandable member and a bone. The surfacing may significantly increase the amount of surface area that comes in contact with the bone resulting in a stronger grip. In some embodiments, the textured surface promotes bone growth onto the expandable member. In some embodiments, the textured surface promotes bone growth of regenerating bone onto the outer surface of the expandable member by grabbing the regenerating bone as it grows. In some embodiments, an expandable member of the present disclosure is made by extruding material into a tube shape, and then forming the tube into a balloon. When forming the tube into the balloon, the balloon can be, for example, pre-stamped or milled to include a desired design, desired shape or surface modification. Then, the tube is heated and radially expanded via compressed air for a specific amount of time. The formed balloon is cooled and includes the desired design, desired shape or surface modification.
In some embodiments, an expandable member of the present disclosure has an outer surface that is coated with materials such as drugs, bone glue, proteins, growth factors, or other coatings. For example, after a minimally invasive surgical procedure an infection may develop in a patient, requiring the patient to undergo antibiotic treatment. An antibiotic drug may be added to an outer surface of an expandable member of the present disclosure to prevent or combat a possible infection. Proteins, such as, for example, bone morphogenic protein or other growth factors have been shown to induce the formation of cartilage and bone. In some embodiments, a growth factor is added to an outer surface of an expandable member of the present disclosure to help induce the formation of new bone. In some embodiments, as the formation of new bone is induced the new bone interacts with a textured outer surface of the expandable member so that new bone is formed onto the textured outer surface of the expandable member. Due to the lack of thermal egress of light-sensitive liquid in an expandable member of the present disclosure, the effectiveness and stability of the coating is maintained.
In some embodiments, a stiffness of any of the expandable member of the present disclosure can be increased due to the presence of external stiffening members or internal stiffening members. In some embodiments, a wrapping, sheathing or an attachment of Nitinol or other metallic memory-type metal piece(s) are aligned in a longitudinal fashion, with multiple rods being placed circumferentially around the expandable member so as to have these metallic pieces change their configuration under a temperature change. In some embodiments, an inner surface of the metallic pieces (those surfaces that are in contact with the external circumferential surface of the intramedullary implant) are polished to increase internal reflection of the light from the light-conducting fiber. The metallic pieces are designed to be load-bearing shapes. In some embodiments, the metallic pieces have a low profile and can handle large loads. In some embodiments, metallic pieces may be positioned on the external circumferential surface of an expandable member. The metallic pieces can be aligned in a longitudinal fashion, circumferentially around the expandable member and can be interconnected with one another via connecting means such as wires. The wires will help hold the longitudinal metallic pieces in position. In some embodiments, the metallic pieces expand to increase the strength of the hardened expandable member. In some embodiments, the metallic pieces contract to increase the strength of the hardened expandable member. In some embodiments, metallic pieces are positioned on an internal circumferential surface of an expandable member. In some embodiments, two metallic memory-type metal wires, such as Nitinol, are positioned within an expandable member. Heat from a light-conducting fiber makes the metal wires get smaller, tensioning the hardened expandable member. In some embodiments, heat from a light-conducting fiber and reaction with the polymerization process, makes the metal wires get smaller, tensioning the hardened expandable member. In some embodiments, an expandable member is wrapped with a plurality of flat metallic plates that move into a corrugated or other shape upon a temperature change to increase the strength of the previously flat metal plate into a shape capable of handling a load. In some embodiments, the metals are rectangular, semicircular, hexagonal, or triangular in section, although not all embodiments are limited to these shapes.
An expandable member typically does not have any valves. One benefit of having no valves is that the expandable member may be inflated or deflated as much as necessary to assist in the fracture reduction and placement. Another benefit of the expandable member having no valves is the efficacy and safety of the implant. Since there is no communication passage of light-sensitive liquid to the body there cannot be any leakage of liquid because all the liquid is contained within the expandable member. In some embodiments, a permanent seal is created between the expandable member that is both hardened and affixed prior to the delivery catheter 101 being removed. The expandable member may have valves, as all of the embodiments are not intended to be limited in this manner.
In some embodiments, an expandable member of the present disclosure includes a pathway sufficiently designed for passing a cooling medium. Once the expandable member is expanded, a cooling media may be delivered within (via an internal lumen) or around (via external tubing) the expandable member in order to prevent the possibility of overheating. Medium used for cooling includes, but is not limited to, gases, liquids and combinations thereof. Examples of gases include, but are not limited to, inert gases and air. Examples of liquids include, but are not limited to, water, saline, saline-ice mixtures, liquid cryogen. In some embodiments, the cooling media is water. The cooling media can be delivered to the expandable member at room temperature or at a cooled temperature. In some embodiments, the cooling media improves the numerical aperture between that of the light-conducting fiber and the inner lumen for the light-conducting fiber because any air existing between the light-conducting fiber and the material of the expandable member is taken away so as to improve light transmission. Therefore, light will be transmitted from the light-conducting fiber to the light-sensitive liquid through the cooling medium as opposed to through air. In some embodiments, the cooling media transmitted through the inner lumen of the expandable member takes away extraneous heat. In some embodiments, no cooling media is used.
In some embodiments, a light-conducting fiber can be introduced into the inner lumen of the expandable member and activated to cure the light-sensitive liquid, while a cooling medium may flow through the inner lumen and out the distal end of the expandable member.
In reference to
The access hole 910 extends through a hard compact (cortical) outer layer 920 of the bone into the relatively porous inner or cancellous tissue 925. For bones with marrow, the medullary material should be cleared from the medullary cavity prior to insertion of the inventive device. Marrow is found mainly in the flat bones such as hip bone, breast bone, skull, ribs, vertebrae and shoulder blades, and in the cancellous material at the proximal ends of the long bones like the femur and humerus. Once the medullary cavity is reached, the medullary material including air, blood, fluids, fat, marrow, tissue and bone debris should be cleared or loosened to form a void. The void is defined as a hollowed out space, wherein a first position defines the most distal edge of the void with relation to the penetration point on the bone, and a second position defines the most proximal edge of the void with relation to the penetration site on the bone. The bone may be hollowed out sufficiently to have the medullary material of the medullary cavity up to the cortical bone removed. There are many methods for removing the medullary material that are known in the art and within the spirit and scope on the presently disclosed embodiments. Methods include those described in U.S. Pat. No. 4,294,251 entitled “Method of Suction Lavage,” U.S. Pat. No. 5,554,111 entitled “Bone Cleaning and Drying system,” U.S. Pat. No. 5,707,974 entitled “Apparatus for Preparing the Medullary Cavity,” U.S. Pat. No. 6,478,751 entitled “Bone Marrow Aspiration Needle,” and U.S. Pat. No. 6,958,252 entitled “Apparatus for Extracting Bone Marrow.”
A guidewire (not shown) may be introduced into the bone 902 via the access hole 910 and placed between bone fragments 904 and 906 of the bone 902 to cross the location of a fracture 905. The guidewire may be delivered into the lumen of the bone 902 and may cross the location of the break 905 so that the guidewire spans multiple sections of bone fragments. As shown in
Once orientation of the bone fragments 904 and 906 are confirmed to be in a desired position, the light-sensitive liquid may be hardened within the expandable member 200, as shown in
In some embodiments, a device for internal bone fixation includes an delivery catheter having a proximal end and a distal end, an expandable member having a proximal region and a distal region, wherein the expandable member is relesably attached about the distal end of the delivery catheter at its proximal region, and a distal cap attached to the distal region of the expandable member to seal the expandable member.
In some embodiments, a device for internal bone fixation includes an delivery catheter having a proximal end and a distal end, a distal cap positioned distally of the delivery catheter, an inner lumen extending through the delivery catheter past the distal end of the delivery catheter for insertion into the distal cap, and an expandable member releasably attached about the distal end of the delivery catheter at its proximal region and is sealed by the distal cap at its distal region.
In some embodiments, a system for internal bone fixation includes an delivery catheter having a proximal end and a distal end; an expandable member having a proximal region and a distal region, wherein the expandable member is relesably attached about the distal end of the delivery catheter at its proximal region, and a distal cap attached to the distal region of the expandable member to seal the expandable member; a light conducting fiber; and a light cure adhesive, wherein the delivery catheter has an inner void for passage of a light-sensitive liquid into the expandable member to expand the expandable member and an inner lumen for passage of a light conducting fiber into the expandable member to cure the light-sensitive liquid inside the expandable member.
In some embodiments, a method for internal bone fixation that includes advancing to a fractured bone a device that includes an delivery catheter having a proximal end and a distal end; an expandable member having a proximal region and a distal region, wherein the expandable member is relesably attached about the distal end of the delivery catheter at its proximal region, and a distal cap attached to the distal region of the expandable member to seal the expandable member; positioning the expandable member of the device within an intramedullary cavity of the fractured bone; expanding the expandable member with a light-sensitive liquid; and curing the light-sensitive liquid within the expandable member.
In some embodiments, a device for bone fixation includes a delivery catheter comprising an outer tube and an inner tube disposed within the outer tube and extending beyond the outer tube; an expandable member having a proximal region and a distal region, the expandable member being relesably attached about a distal end of the delivery catheter at the proximal region of the expandable member, and a distal cap attached to the distal region of the expandable member to seal the expandable member; and an inner compartment in the distal region of the expandable member, the inner compartment being configured to receive the inner tube and enable movement of the inner tube within the inner compartment.
In some embodiments, a system for bone fixation includes a delivery catheter having a proximal end and a distal end; an expandable member having a proximal region and a distal region, wherein the expandable member is releasably attached about the distal end of the delivery catheter at the proximal region of the expandable member; a distal cap attached to the distal region of the expandable member to seal the expandable member; a light conducting fiber; and a light-sensitive liquid; wherein the delivery catheter has an inner void for passage of a light-sensitive liquid into the expandable member to expand the expandable member and an inner lumen for passage of the light conducting fiber into the expandable member to cure the light-sensitive liquid inside the expandable member.
In some embodiments, a method for bone fixation includes advancing to a fractured bone a device comprising a delivery catheter having a proximal end and a distal end; an expandable member having a proximal region and a distal region, wherein the expandable member is attached about the distal end of the delivery catheter at the proximal region of the expandable member; and a distal cap attached to the distal region of the expandable member to seal the expandable member; positioning the expandable member within an intramedullary cavity of the fractured bone; expanding the expandable member with a light-sensitive liquid; and curing the light-sensitive liquid within the expandable member.
All patents, patent applications, and published references cited herein are hereby incorporated by reference in their entirety. It should be emphasized that the above-described embodiments of the present disclosure are merely possible examples of implementations, merely set forth for a clear understanding of the principles of the disclosure. Many variations and modifications may be made to the above-described embodiment(s) without departing substantially from the spirit and principles of the disclosure. It will be appreciated that several of the above-disclosed and other features and functions, or alternatives thereof, may be desirably combined into many other different systems or applications. All such modifications and variations are intended to be included herein within the scope of this disclosure, and as fall within the scope of the appended claims
This application claims the benefit of and priority to U.S. Provisional Application No. 61/739,972, which was filed on Dec. 20, 2012, and which is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3485520 | Alexander | Dec 1969 | A |
4271839 | Fogarty et al. | Jun 1981 | A |
4280233 | Raab | Jul 1981 | A |
4294251 | Greenwald et al. | Oct 1981 | A |
4313434 | Segal | Feb 1982 | A |
4341691 | Anuta | Jul 1982 | A |
4369772 | Miller | Jan 1983 | A |
4414608 | Furihata | Nov 1983 | A |
4422719 | Orcutt | Dec 1983 | A |
4433898 | Nasiri | Feb 1984 | A |
4462394 | Jacobs | Jul 1984 | A |
4466435 | Murray | Aug 1984 | A |
4562598 | Kranz | Jan 1986 | A |
4686973 | Frisch | Aug 1987 | A |
4697584 | Haynes | Oct 1987 | A |
4735625 | Davidson | Apr 1988 | A |
4870953 | DonMicheal et al. | Oct 1989 | A |
4888024 | Powlan | Dec 1989 | A |
4892550 | Huebsch | Jan 1990 | A |
4904391 | Freeman | Feb 1990 | A |
4961424 | Kubota et al. | Oct 1990 | A |
4963151 | Ducheyne et al. | Oct 1990 | A |
4969888 | Scholten et al. | Nov 1990 | A |
5030093 | Mitnick | Jul 1991 | A |
5049157 | Mittelmeier et al. | Sep 1991 | A |
5085660 | Lin | Feb 1992 | A |
5092899 | Forte | Mar 1992 | A |
5102413 | Poddar | Apr 1992 | A |
5108404 | Scholten et al. | Apr 1992 | A |
5112333 | Fixel | May 1992 | A |
5207669 | Baker et al. | May 1993 | A |
5222958 | Chin | Jun 1993 | A |
5295733 | LeBegue | Mar 1994 | A |
5295962 | Crocker et al. | Mar 1994 | A |
5303718 | Krajicek | Apr 1994 | A |
5316550 | Forte | May 1994 | A |
5336699 | Cooke et al. | Aug 1994 | A |
5372598 | Luhr et al. | Dec 1994 | A |
5376123 | Klaue et al. | Dec 1994 | A |
5391144 | Sakurai et al. | Feb 1995 | A |
5415654 | Daikuzono | May 1995 | A |
5423850 | Berger | Jun 1995 | A |
5432876 | Appeldorn et al. | Jul 1995 | A |
5443468 | Johnson | Aug 1995 | A |
5445608 | Chen et al. | Aug 1995 | A |
5462552 | Kiester | Oct 1995 | A |
5480400 | Berger | Jan 1996 | A |
5538514 | Hawkins | Jul 1996 | A |
5548676 | Savage, Jr. | Aug 1996 | A |
5554111 | Morrey et al. | Sep 1996 | A |
5556429 | Felt | Sep 1996 | A |
5571204 | Nies | Nov 1996 | A |
5658310 | Berger | Aug 1997 | A |
5658963 | Qian et al. | Aug 1997 | A |
5705181 | Cooper et al. | Jan 1998 | A |
5707374 | Schmidt | Jan 1998 | A |
5713901 | Tock | Feb 1998 | A |
5795353 | Felt | Aug 1998 | A |
5824087 | Aspden et al. | Oct 1998 | A |
5827289 | Reiley et al. | Oct 1998 | A |
5888220 | Felt et al. | Mar 1999 | A |
5897557 | Chin et al. | Apr 1999 | A |
5908433 | Eager et al. | Jun 1999 | A |
5930424 | Heimberger et al. | Jul 1999 | A |
5972015 | Scribner et al. | Oct 1999 | A |
5980075 | Sheaffer | Nov 1999 | A |
5980253 | Oxman et al. | Nov 1999 | A |
5987199 | Zarian et al. | Nov 1999 | A |
5989230 | Frassica | Nov 1999 | A |
5997570 | Ligtenberg et al. | Dec 1999 | A |
6008264 | Ostler | Dec 1999 | A |
6019761 | Gustilo | Feb 2000 | A |
6019774 | Weiss et al. | Feb 2000 | A |
6033411 | Preissman | Mar 2000 | A |
6039762 | McKay | Mar 2000 | A |
6042380 | De Rowe | Mar 2000 | A |
6048346 | Reiley et al. | Apr 2000 | A |
6053917 | Sherman et al. | Apr 2000 | A |
6059789 | Dinger et al. | May 2000 | A |
6066154 | Reiley et al. | May 2000 | A |
6077265 | Werding et al. | Jun 2000 | A |
6079868 | Rydell | Jun 2000 | A |
6103203 | Fischer | Aug 2000 | A |
6110176 | Shapira | Aug 2000 | A |
6121341 | Sawhney et al. | Sep 2000 | A |
6127597 | Beyar et al. | Oct 2000 | A |
6136011 | Stambaugh | Oct 2000 | A |
6140452 | Felt et al. | Oct 2000 | A |
6159236 | Biel | Dec 2000 | A |
6179852 | Strickland et al. | Jan 2001 | B1 |
6195477 | Denuto et al. | Feb 2001 | B1 |
6200134 | Kovac et al. | Mar 2001 | B1 |
6217581 | Tolson | Apr 2001 | B1 |
6223085 | Dann et al. | Apr 2001 | B1 |
6224630 | Bao et al. | May 2001 | B1 |
6235043 | Reiley | May 2001 | B1 |
6241734 | Scribner et al. | Jun 2001 | B1 |
6248110 | Reiley et al. | Jun 2001 | B1 |
6248131 | Felt et al. | Jun 2001 | B1 |
6254571 | Hart | Jul 2001 | B1 |
6258089 | Campbell et al. | Jul 2001 | B1 |
6261289 | Levy | Jul 2001 | B1 |
6280456 | Scribner et al. | Aug 2001 | B1 |
6282013 | Ostler et al. | Aug 2001 | B1 |
6290382 | Bourn et al. | Sep 2001 | B1 |
6299597 | Buscemi et al. | Oct 2001 | B1 |
6306177 | Felt et al. | Oct 2001 | B1 |
6319255 | Grundei et al. | Nov 2001 | B1 |
6332894 | Stalcup et al. | Dec 2001 | B1 |
6336914 | Gillespie, III | Jan 2002 | B1 |
6336930 | Stalcup et al. | Jan 2002 | B1 |
6358252 | Shapira | Mar 2002 | B1 |
6387098 | Cole et al. | May 2002 | B1 |
6395007 | Bhatnagar et al. | May 2002 | B1 |
6416531 | Chen | Jul 2002 | B2 |
6416737 | Manolagas et al. | Jul 2002 | B1 |
6419483 | Adam et al. | Jul 2002 | B1 |
6423055 | Farr et al. | Jul 2002 | B1 |
6423083 | Reiley et al. | Jul 2002 | B2 |
6425923 | Stalcup et al. | Jul 2002 | B1 |
6440444 | Boyce et al. | Aug 2002 | B2 |
6443988 | Felt et al. | Sep 2002 | B2 |
6447514 | Stalcup et al. | Sep 2002 | B1 |
6458375 | Gertzman et al. | Oct 2002 | B1 |
6478751 | Krueger et al. | Nov 2002 | B1 |
6482234 | Weber et al. | Nov 2002 | B1 |
6485512 | Cheng | Nov 2002 | B1 |
6494883 | Ferree | Dec 2002 | B1 |
6524251 | Rabiner et al. | Feb 2003 | B2 |
6524313 | Fassier et al. | Feb 2003 | B1 |
6551321 | Burkinshaw et al. | Apr 2003 | B1 |
6551337 | Rabiner et al. | Apr 2003 | B1 |
6565528 | Mueller | May 2003 | B1 |
6579277 | Rabiner et al. | Jun 2003 | B1 |
6579279 | Rabiner et al. | Jun 2003 | B1 |
6605056 | Eidenschink et al. | Aug 2003 | B2 |
6620185 | Harvie et al. | Sep 2003 | B1 |
6623505 | Scribner et al. | Sep 2003 | B2 |
6632235 | Weikel et al. | Oct 2003 | B2 |
6648881 | KenKnight et al. | Nov 2003 | B2 |
6652547 | Rabiner et al. | Nov 2003 | B2 |
6652587 | Felt et al. | Nov 2003 | B2 |
6660013 | Rabiner et al. | Dec 2003 | B2 |
6679873 | Rabiner et al. | Jan 2004 | B2 |
6695781 | Rabiner et al. | Feb 2004 | B2 |
6695782 | Rabiner et al. | Feb 2004 | B2 |
6696073 | Boyce et al. | Feb 2004 | B2 |
6716216 | Boucher et al. | Apr 2004 | B1 |
6719773 | Boucher et al. | Apr 2004 | B1 |
6726691 | Osorio et al. | Apr 2004 | B2 |
6730048 | Hare et al. | May 2004 | B1 |
6733451 | Rabiner et al. | May 2004 | B2 |
6733513 | Boyle et al. | May 2004 | B2 |
6740093 | Hochschuler et al. | May 2004 | B2 |
6755862 | Keynan | Jun 2004 | B2 |
6783530 | Levy | Aug 2004 | B1 |
6802835 | Rabiner et al. | Oct 2004 | B2 |
6818018 | Sawhney | Nov 2004 | B1 |
6852095 | Ray | Feb 2005 | B1 |
6866678 | Shenderova et al. | Mar 2005 | B2 |
6869442 | Cheng | Mar 2005 | B2 |
6875212 | Shaolian et al. | Apr 2005 | B2 |
6885246 | Tsutsui et al. | Apr 2005 | B2 |
6887246 | Bhatnagar et al. | May 2005 | B2 |
6887275 | Carchidi et al. | May 2005 | B2 |
6899713 | Shaolian et al. | May 2005 | B2 |
6899719 | Reiley et al. | May 2005 | B2 |
6932843 | Smith et al. | Aug 2005 | B2 |
6964667 | Shaolian et al. | Nov 2005 | B2 |
6975898 | Seibel | Dec 2005 | B2 |
6979341 | Scribner et al. | Dec 2005 | B2 |
6981981 | Reiley et al. | Jan 2006 | B2 |
7001431 | Bao et al. | Feb 2006 | B2 |
7008433 | Voellmicke et al. | Mar 2006 | B2 |
7048731 | Altshuler | May 2006 | B2 |
7052498 | Levy et al. | May 2006 | B2 |
7077865 | Bao et al. | Jul 2006 | B2 |
7124067 | Ascenzi | Oct 2006 | B2 |
7141061 | Williams et al. | Nov 2006 | B2 |
7144414 | Harvie et al. | Dec 2006 | B2 |
7153305 | Johnson et al. | Dec 2006 | B2 |
7156861 | Scribner et al. | Jan 2007 | B2 |
7156880 | Evans et al. | Jan 2007 | B2 |
7169140 | Kume | Jan 2007 | B1 |
7215863 | Arenella et al. | May 2007 | B1 |
7241303 | Reiss et al. | Jul 2007 | B2 |
7252677 | Burwell et al. | Aug 2007 | B2 |
7258692 | Thelen et al. | Aug 2007 | B2 |
7261720 | Stevens et al. | Aug 2007 | B2 |
7320709 | Felt et al. | Jan 2008 | B2 |
7341601 | Eisermann et al. | Mar 2008 | B2 |
7360542 | Nelson et al. | Apr 2008 | B2 |
7407616 | Melikechi et al. | Aug 2008 | B2 |
7419450 | Ito | Sep 2008 | B2 |
7427295 | Ellman et al. | Sep 2008 | B2 |
7465318 | Sennett et al. | Dec 2008 | B2 |
7547319 | Segal et al. | Jun 2009 | B2 |
7621950 | Globerman et al. | Nov 2009 | B1 |
7628800 | Sherman et al. | Dec 2009 | B2 |
7632277 | Woll et al. | Dec 2009 | B2 |
7632291 | Stephens et al. | Dec 2009 | B2 |
7666205 | Weikel et al. | Feb 2010 | B2 |
7722620 | Truckai et al. | May 2010 | B2 |
7740656 | Mensah et al. | Jun 2010 | B2 |
7744555 | DiMauro et al. | Jun 2010 | B2 |
7766965 | Bao et al. | Aug 2010 | B2 |
7771476 | Justis et al. | Aug 2010 | B2 |
7776075 | Bruneau et al. | Aug 2010 | B2 |
7806900 | Rabiner | Oct 2010 | B2 |
7811284 | Rabiner et al. | Oct 2010 | B2 |
7811286 | Medoff | Oct 2010 | B2 |
7811290 | Rabiner | Oct 2010 | B2 |
7842040 | Rabiner et al. | Nov 2010 | B2 |
7850711 | Stone et al. | Dec 2010 | B1 |
7857748 | Williams et al. | Dec 2010 | B2 |
7879041 | Rabiner | Feb 2011 | B2 |
7912539 | Doty et al. | Mar 2011 | B2 |
7947015 | Herweck et al. | May 2011 | B2 |
8034071 | Scribner et al. | Oct 2011 | B2 |
8123807 | Kim et al. | Feb 2012 | B2 |
8187278 | Biel | May 2012 | B2 |
8210729 | O'Leary et al. | Jul 2012 | B2 |
8211121 | Quinn et al. | Jul 2012 | B1 |
8246628 | Rabiner | Aug 2012 | B2 |
8262694 | Widomski et al. | Sep 2012 | B2 |
8328402 | O'Leary et al. | Dec 2012 | B2 |
8348956 | Rabiner | Jan 2013 | B2 |
8366711 | Rabiner et al. | Feb 2013 | B2 |
8403968 | Rabiner et al. | Mar 2013 | B2 |
8413664 | Appling | Apr 2013 | B2 |
8512338 | Rabiner et al. | Aug 2013 | B2 |
8545499 | Lozier et al. | Oct 2013 | B2 |
8574233 | Rabiner et al. | Nov 2013 | B2 |
8668701 | Rabiner | Mar 2014 | B2 |
8672982 | Rabiner et al. | Mar 2014 | B2 |
8684965 | Rabiner et al. | Apr 2014 | B2 |
8708955 | Tilson et al. | Apr 2014 | B2 |
8734460 | Rabiner et al. | May 2014 | B2 |
8764761 | Truckai et al. | Jul 2014 | B2 |
8870965 | Rabiner et al. | Oct 2014 | B2 |
8906030 | Rabiner et al. | Dec 2014 | B2 |
8906031 | Rabiner et al. | Dec 2014 | B2 |
8915966 | Rabiner et al. | Dec 2014 | B2 |
8936382 | O'Leary et al. | Jan 2015 | B2 |
8936644 | Rabiner et al. | Jan 2015 | B2 |
8939977 | DiPoto et al. | Jan 2015 | B2 |
9005254 | Rabiner et al. | Apr 2015 | B2 |
9050079 | Rabiner et al. | Jun 2015 | B2 |
9101419 | Colleran et al. | Aug 2015 | B2 |
9125706 | Rabiner et al. | Sep 2015 | B2 |
9144442 | Rabiner et al. | Sep 2015 | B2 |
9179959 | Rabiner et al. | Nov 2015 | B2 |
9216049 | Rabiner et al. | Dec 2015 | B2 |
9254156 | Rabiner | Feb 2016 | B2 |
9254195 | Rabiner et al. | Feb 2016 | B2 |
9265549 | Rabiner | Feb 2016 | B2 |
9427289 | Rabiner et al. | Aug 2016 | B2 |
9433450 | Rabiner et al. | Sep 2016 | B2 |
20010011174 | Reiley et al. | Aug 2001 | A1 |
20010044626 | Reiley et al. | Nov 2001 | A1 |
20010055462 | Seibel | Dec 2001 | A1 |
20020032444 | Mische | Mar 2002 | A1 |
20020082600 | Shaolian et al. | Jun 2002 | A1 |
20020091424 | Biel | Jul 2002 | A1 |
20020156482 | Scribner et al. | Oct 2002 | A1 |
20020161373 | Osorio et al. | Oct 2002 | A1 |
20020165544 | Perren et al. | Nov 2002 | A1 |
20020198526 | Shaolian et al. | Dec 2002 | A1 |
20030028210 | Boyle et al. | Feb 2003 | A1 |
20030083642 | Boyd et al. | May 2003 | A1 |
20030105469 | Karmon | Jun 2003 | A1 |
20030114914 | Cheng | Jun 2003 | A1 |
20030156431 | Gozum et al. | Aug 2003 | A1 |
20030199850 | Chavez et al. | Oct 2003 | A1 |
20030212426 | Olson et al. | Nov 2003 | A1 |
20030229372 | Reiley et al. | Dec 2003 | A1 |
20040006341 | Shaolian et al. | Jan 2004 | A1 |
20040024388 | Altshuler | Feb 2004 | A1 |
20040034434 | Evans et al. | Feb 2004 | A1 |
20040059333 | Carl et al. | Mar 2004 | A1 |
20040059417 | Smith et al. | Mar 2004 | A1 |
20040092948 | Stevens et al. | May 2004 | A1 |
20040098015 | Weikel et al. | May 2004 | A1 |
20040117025 | Reindel | Jun 2004 | A1 |
20040133280 | Trieu | Jul 2004 | A1 |
20040167561 | Boucher et al. | Aug 2004 | A1 |
20040167625 | Beyar et al. | Aug 2004 | A1 |
20040225296 | Reiss et al. | Nov 2004 | A1 |
20040228142 | Takada et al. | Nov 2004 | A1 |
20040230309 | DiMauro et al. | Nov 2004 | A1 |
20040236366 | Kennedy, II | Nov 2004 | A1 |
20040247641 | Felt et al. | Dec 2004 | A1 |
20050010231 | Myers | Jan 2005 | A1 |
20050010297 | Watson et al. | Jan 2005 | A1 |
20050015140 | deBeer | Jan 2005 | A1 |
20050015148 | Jansen et al. | Jan 2005 | A1 |
20050018989 | Shimizu et al. | Jan 2005 | A1 |
20050033437 | Bao et al. | Feb 2005 | A1 |
20050043733 | Eisermann et al. | Feb 2005 | A1 |
20050043808 | Felt et al. | Feb 2005 | A1 |
20050049691 | Mericle et al. | Mar 2005 | A1 |
20050090901 | Studer | Apr 2005 | A1 |
20050119662 | Reiley et al. | Jun 2005 | A1 |
20050142315 | DeSimone et al. | Jun 2005 | A1 |
20050149022 | Shaolian et al. | Jul 2005 | A1 |
20050159749 | Levy et al. | Jul 2005 | A1 |
20050171604 | Michalow | Aug 2005 | A1 |
20050192671 | Bao et al. | Sep 2005 | A1 |
20050197711 | Cachia | Sep 2005 | A1 |
20050228260 | Burwell et al. | Oct 2005 | A1 |
20050234453 | Shaolian et al. | Oct 2005 | A1 |
20050251140 | Shaolian et al. | Nov 2005 | A1 |
20050284485 | Nelson et al. | Dec 2005 | A9 |
20060009550 | Messersmith et al. | Jan 2006 | A1 |
20060015105 | Warren et al. | Jan 2006 | A1 |
20060036253 | Leroux et al. | Feb 2006 | A1 |
20060084985 | Kim et al. | Apr 2006 | A1 |
20060100547 | Rabiner et al. | May 2006 | A1 |
20060100635 | Reiley et al. | May 2006 | A1 |
20060100706 | Shadduck et al. | May 2006 | A1 |
20060111726 | Felt et al. | May 2006 | A1 |
20060122625 | Truckai et al. | Jun 2006 | A1 |
20060142747 | Appling | Jun 2006 | A1 |
20060155296 | Richter | Jul 2006 | A1 |
20060173464 | Ellman et al. | Aug 2006 | A1 |
20060183811 | Melikechi et al. | Aug 2006 | A1 |
20060184246 | Zwirkoski | Aug 2006 | A1 |
20060195165 | Gertner et al. | Aug 2006 | A1 |
20060217747 | Ferree | Sep 2006 | A1 |
20060229617 | Meller et al. | Oct 2006 | A1 |
20060229625 | Truckai et al. | Oct 2006 | A1 |
20060247787 | Rydell et al. | Nov 2006 | A1 |
20060253102 | Nance et al. | Nov 2006 | A1 |
20060253200 | Bao et al. | Nov 2006 | A1 |
20060258981 | Eidenschink | Nov 2006 | A1 |
20060264950 | Nelson et al. | Nov 2006 | A1 |
20060264951 | Nelson et al. | Nov 2006 | A1 |
20060264952 | Nelson et al. | Nov 2006 | A1 |
20060265077 | Zwirkoski | Nov 2006 | A1 |
20060271024 | Gertner et al. | Nov 2006 | A1 |
20060271061 | Beyar et al. | Nov 2006 | A1 |
20060276793 | Berry | Dec 2006 | A1 |
20060276819 | Osorio et al. | Dec 2006 | A1 |
20060282169 | Felt et al. | Dec 2006 | A1 |
20060287730 | Segal et al. | Dec 2006 | A1 |
20070027547 | Rydell et al. | Feb 2007 | A1 |
20070067032 | Felt et al. | Mar 2007 | A1 |
20070087031 | Ashman et al. | Apr 2007 | A1 |
20070100327 | Smith | May 2007 | A1 |
20070104416 | Shimizu et al. | May 2007 | A1 |
20070118143 | Ralph et al. | May 2007 | A1 |
20070123876 | Czartoski et al. | May 2007 | A1 |
20070123877 | Goldin et al. | May 2007 | A1 |
20070123878 | Shaver et al. | May 2007 | A1 |
20070161991 | Altarac et al. | Jul 2007 | A1 |
20070198023 | Sand et al. | Aug 2007 | A1 |
20070225705 | Osario et al. | Sep 2007 | A1 |
20070233146 | Henniges et al. | Oct 2007 | A1 |
20070239148 | Scheller | Oct 2007 | A1 |
20070255287 | Rabiner | Nov 2007 | A1 |
20080015500 | Herweck et al. | Jan 2008 | A1 |
20080019657 | Maitland et al. | Jan 2008 | A1 |
20080021474 | Bonutti et al. | Jan 2008 | A1 |
20080039854 | Rabiner | Feb 2008 | A1 |
20080080205 | Forrester et al. | Apr 2008 | A1 |
20080103505 | Fransen | May 2008 | A1 |
20080125784 | Rabiner et al. | May 2008 | A1 |
20080154266 | Protopsaltis et al. | Jun 2008 | A1 |
20080154368 | Justis | Jun 2008 | A1 |
20080154373 | Protopsaltis et al. | Jun 2008 | A1 |
20080183122 | Fisher et al. | Jul 2008 | A1 |
20080188805 | Davies et al. | Aug 2008 | A1 |
20080188858 | Luzzi et al. | Aug 2008 | A1 |
20080234820 | Felt et al. | Sep 2008 | A1 |
20080249529 | Zarda et al. | Oct 2008 | A1 |
20080255560 | Myers et al. | Oct 2008 | A1 |
20080269750 | Justin | Oct 2008 | A1 |
20080287951 | Stoneburger et al. | Nov 2008 | A1 |
20080308753 | Stuba et al. | Dec 2008 | A1 |
20090005782 | Chirico et al. | Jan 2009 | A1 |
20090018524 | Greenhalgh et al. | Jan 2009 | A1 |
20090024166 | Carl et al. | Jan 2009 | A1 |
20090048629 | Rabiner | Feb 2009 | A1 |
20090054900 | Rabiner et al. | Feb 2009 | A1 |
20090076610 | Afzal et al. | Mar 2009 | A1 |
20090093887 | Walter et al. | Apr 2009 | A1 |
20090112196 | Rabiner et al. | Apr 2009 | A1 |
20090118833 | Hudgins et al. | May 2009 | A1 |
20090125028 | Teisen et al. | May 2009 | A1 |
20090171265 | Doty et al. | Jul 2009 | A1 |
20090171358 | Chang et al. | Jul 2009 | A1 |
20090177204 | Colleran et al. | Jul 2009 | A1 |
20090182336 | Brenzel et al. | Jul 2009 | A1 |
20090187192 | Rabiner et al. | Jul 2009 | A1 |
20090216232 | Buford, III et al. | Aug 2009 | A1 |
20090228007 | Justin et al. | Sep 2009 | A1 |
20090254064 | Boatman | Oct 2009 | A1 |
20090287309 | Walch et al. | Nov 2009 | A1 |
20090306589 | Tilson et al. | Dec 2009 | A1 |
20100076503 | Beyar et al. | Mar 2010 | A1 |
20100234958 | Linares | Sep 2010 | A1 |
20100241178 | Tilson et al. | Sep 2010 | A1 |
20100249942 | Goswami et al. | Sep 2010 | A1 |
20100256641 | Rabiner et al. | Oct 2010 | A1 |
20100262069 | Rabiner et al. | Oct 2010 | A1 |
20100262188 | Rabiner et al. | Oct 2010 | A1 |
20100265733 | O'Leary et al. | Oct 2010 | A1 |
20100318087 | Scribner et al. | Dec 2010 | A1 |
20100331850 | Rabiner | Dec 2010 | A1 |
20110004213 | Rabiner et al. | Jan 2011 | A1 |
20110009871 | Rabiner | Jan 2011 | A1 |
20110029093 | Bojarski et al. | Feb 2011 | A1 |
20110046746 | Rabiner et al. | Feb 2011 | A1 |
20110077651 | Lozier et al. | Mar 2011 | A1 |
20110082504 | Singhatt et al. | Apr 2011 | A1 |
20110098713 | Rabiner et al. | Apr 2011 | A1 |
20110110114 | Papac et al. | May 2011 | A1 |
20110112588 | Linderman et al. | May 2011 | A1 |
20110118740 | Rabiner et al. | May 2011 | A1 |
20110137317 | O'Halloran et al. | Jun 2011 | A1 |
20110160870 | Baumgartner et al. | Jun 2011 | A1 |
20110166306 | Stansbury et al. | Jul 2011 | A1 |
20110218626 | Krinke et al. | Sep 2011 | A1 |
20110268866 | Parker | Nov 2011 | A1 |
20110288522 | Hollowel et al. | Nov 2011 | A1 |
20110313356 | Rabiner et al. | Dec 2011 | A1 |
20120016371 | O'Halloran et al. | Jan 2012 | A1 |
20120022540 | Chasmawala et al. | Jan 2012 | A1 |
20120029102 | Rose et al. | Feb 2012 | A1 |
20120041557 | Frigg | Feb 2012 | A1 |
20120165941 | Rabiner et al. | Jun 2012 | A1 |
20120259375 | Druma et al. | Oct 2012 | A1 |
20120262939 | O'Leary et al. | Oct 2012 | A1 |
20120289968 | Rabiner | Nov 2012 | A1 |
20120316652 | Renganath et al. | Dec 2012 | A1 |
20130003406 | O'Leary et al. | Jan 2013 | A1 |
20130006304 | Rabiner et al. | Jan 2013 | A1 |
20130012998 | Altarac et al. | Jan 2013 | A1 |
20130013008 | Rabiner et al. | Jan 2013 | A1 |
20130013009 | Colleran et al. | Jan 2013 | A1 |
20130013010 | Rabiner et al. | Jan 2013 | A1 |
20130018482 | Meridew et al. | Jan 2013 | A1 |
20130023876 | Rabiner et al. | Jan 2013 | A1 |
20130023877 | Rabiner et al. | Jan 2013 | A1 |
20130023886 | Rabiner et al. | Jan 2013 | A1 |
20130041472 | Rabiner et al. | Feb 2013 | A1 |
20130046390 | Rabiner et al. | Feb 2013 | A1 |
20130066326 | Rabiner et al. | Mar 2013 | A1 |
20130158607 | Rabiner et al. | Jun 2013 | A1 |
20130184715 | Rabiner et al. | Jul 2013 | A1 |
20130310875 | Rabiner et al. | Nov 2013 | A1 |
20140018806 | DiPoto et al. | Jan 2014 | A1 |
20140135847 | Rabiner et al. | May 2014 | A1 |
20140142581 | Rabiner | May 2014 | A1 |
20140148813 | Rabiner | May 2014 | A1 |
20140163453 | Rabiner et al. | Jun 2014 | A1 |
20150066028 | Rabiner et al. | Mar 2015 | A1 |
20150066085 | Rabiner et al. | Mar 2015 | A1 |
20150080900 | Rabiner et al. | Mar 2015 | A1 |
20150088268 | Rabiner et al. | Mar 2015 | A1 |
20150374498 | Rabiner et al. | Dec 2015 | A1 |
20160022333 | Rabiner et al. | Jan 2016 | A1 |
20160128750 | Rabiner et al. | May 2016 | A1 |
20160128836 | Rabiner et al. | May 2016 | A1 |
Number | Date | Country |
---|---|---|
40 28 466 | Mar 1992 | DE |
0 709 698 | May 1996 | EP |
2 298 201 | Mar 2011 | EP |
2001-527437 | Dec 2001 | JP |
2004-526525 | Sep 2002 | JP |
2005-511143 | Apr 2005 | JP |
2006-212425 | Aug 2006 | JP |
9001858 | Mar 1992 | NL |
WO 9838918 | Sep 1998 | WO |
WO9943266 | Sep 1999 | WO |
0230338 | Apr 2002 | WO |
WO 0243628 | Jun 2002 | WO |
WO 03047472 | Jun 2003 | WO |
WO 2004045393 | Jun 2004 | WO |
WO 2004058045 | Jul 2004 | WO |
WO 2004073563 | Sep 2004 | WO |
WO 2004112661 | Dec 2004 | WO |
2005102224 | Nov 2005 | WO |
WO 2005112804 | Dec 2005 | WO |
WO 2006016807 | Feb 2006 | WO |
WO2007002251 | Jan 2007 | WO |
WO 2007059259 | May 2007 | WO |
WO 2007075375 | Jul 2007 | WO |
WO 2007127255 | Nov 2007 | WO |
WO 2007127260 | Nov 2007 | WO |
2008021972 | Feb 2008 | WO |
WO 2008039811 | Apr 2008 | WO |
WO 2008063265 | May 2008 | WO |
2008096363 | Aug 2008 | WO |
WO 2009059090 | May 2009 | WO |
WO 2009064847 | May 2009 | WO |
2009091811 | Jul 2009 | WO |
WO 2009082688 | Jul 2009 | WO |
WO2009088927 | Jul 2009 | WO |
WO 2009131999 | Oct 2009 | WO |
WO 2010050965 | May 2010 | WO |
WO 2010118158 | Oct 2010 | WO |
WO 2011060062 | May 2011 | WO |
2011006652 | Jun 2011 | WO |
WO 2011071567 | Jun 2011 | WO |
WO 2011162910 | Dec 2011 | WO |
WO2011162910 | Dec 2011 | WO |
2012050583 | Apr 2012 | WO |
WO2012051312 | Apr 2012 | WO |
WO 2012088432 | Jun 2012 | WO |
WO 2013013069 | Jan 2013 | WO |
WO 2013013071 | Jan 2013 | WO |
WO 2013013072 | Jan 2013 | WO |
WO2013059609 | Apr 2013 | WO |
WO2014011669 | Jan 2014 | WO |
WO 2014100427 | Jun 2014 | WO |
Entry |
---|
Jovanovic et al., “Fixion Nails for Humeral Fractures, Injury”, Int. J. Care Injured, vol. 35, Issue 11, pp. 1140-1142, Nov. 2004. |
Maruyama et al., “Metacarpal Fracture Fixation with Absorbable Polyglycolide Rods and Stainless Steel K Wires: A Biomechanical Comparison”, Journal of Biomedical Materials Research (Applied Biomaterials), vol. 33, Issue 1, pp. 9-12, Apr. 1996. |
Waris et al., “Bioabsorbable Miniplating Versus Metallic Fixation for Metacarpal Fractures”, Clinical Orthopaedics and Related Research, No. 410, pp. 310-319, May 2003. |
Waris et al., “Self-Reinforced Bioabsorbable Versus Metallic Fixation Systems for Metacarpal and Phalangeal Fractures: A Biomechanical Study”, The Journal of Hand Surgery, vol. 27A, No. 5, pp. 902-909, Sep. 2002. |
PCT International Search Report based on PCT/US07/20402 dated Apr. 1, 2008. |
PCT International Search Report based on PCT/US07/10050 dated Apr. 17, 2008. |
PCT International Search Report based on PCT/US07/10038 dated Aug. 27, 2008. |
PCT International Search Report based on PCT/US08/81929 dated Jan. 12, 2009. |
PCT International Search Report based on PCT/US08/81924 dated Feb. 9, 2009. |
PCT International Search Report based on PCT/US08/87630 dated Feb. 24, 2009. |
PCT International Search Report based on PCT/US10/30275 dated Aug. 11, 2010. |
PCT International Search Report based on PCT/US10/56219 dated Jan. 20, 2011. |
PCT International Search Report based on PCT/US10/46003 dated May 24, 2011. |
PCT International Search Report based on PCT/US11/38389 dated Sep. 22, 2011. |
PCT International Search Report based on PCT/US11/66871 dated May 1, 2012. |
USPTO Office Action in U.S. Appl. No. 11/789,906 mailed Apr. 29, 2009. |
USPTO Office Action in U.S. Appl. No. 11/789,906 mailed Mar. 11, 2010. |
USPTO Office Action in U.S. Appl. No. 11/789,906 mailed Apr. 30, 2010. |
USPTO Office Action in U.S. Appl. No. 11/789,907 mailed May 11, 2010. |
USPTO Office Action in U.S. Appl. No. 11/903,123 mailed Jul. 1, 2010. |
USPTO Office Action in U.S. Appl. No. 11/964,370 mailed Dec. 9, 2010. |
USPTO Office Action in U.S. Appl. No. 11/964,370 mailed Apr. 28, 2011. |
USPTO Office Action in U.S. Appl. No. 11/964,370 mailed Sep. 23, 2011. |
USPTO Office Action in U.S. Appl. No. 11/964,370 mailed Mar. 16, 2012. |
USPTO Office Action in U.S. Appl. No. 12/262,411 mailed Sep. 1, 2010. |
USPTO Office Action in U.S. Appl. No. 12/755,784 mailed Dec. 23, 2011. |
USPTO Office Action in U.S. Appl. No. 12/756,014 mailed May 11, 2012. |
USPTO Office Action in U.S. Appl. No. 12/858,924 mailed Oct. 24, 2011. |
USPTO Office Action in U.S. Appl. No. 12/858,924 mailed Apr. 4, 2012. |
USPTO Office Action in U.S. Appl. No. 12/875,460 mailed Mar. 8, 2012. |
USPTO Office Action in U.S. Appl. No. 12/886,288 mailed Dec. 27, 2011. |
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed May 29, 2012. |
USPTO Office Action in U.S. Appl. No. 12/943,544 mailed Jun. 8, 2012. |
USPTO Office Action in U.S. Appl. No. 12/886,288 mailed Jun. 26, 2012. |
USPTO Office Action in U.S. Appl. No. 11/964,370 mailed Jul. 6, 2012. |
Extended European Search Report based on EP 07 75 6022 dated Jul. 30, 2012. |
Extended European Search Report based on EP 07 75 6016 dated Jul. 30, 2012. |
USPTO Office Action in U.S. Appl. No. 12/755,784 mailed Aug. 1, 2012. |
USPTO Office Action in U.S. Appl. No. 12/858,924 mailed Aug. 2, 2012. |
USPTO Office Action inU.S. Appl. No. 12/886,288 mailed Aug. 15, 2012. |
PCT International Search Report based on PCT/US12/47447 dated Oct. 2, 2012. |
PCT International Search Report based on PCT/US12/47446 dated Oct. 15, 2012. |
PCT International Search Report based on PCT/US12/47444 dated Oct. 18, 2012. |
USPTO Office Action in U.S. Appl. No. 12/756,014 mailed Oct. 25, 2012. |
USPTO Office Action in U.S. Appl. No. 12/859,680 mailed Nov. 9, 2012. |
USPTO Office Action in U.S. Appl. No. 12/943,544 mailed Dec. 3, 2012. |
USPTO Office Action in U.S. Appl. No. 12/859,680 mailed Jan. 17, 2013. |
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed Dec. 14, 2012. |
International Search Report and Written Opinion for PCT/US2012/061047 mailed Jan. 7, 2013. |
USPTO Office Action in U.S. Appl. No. 12/756,014 mailed Jan. 22, 2013. |
USPTO Office Action in U.S. Appl. No. 13/088,916 mailed Jan. 23, 2013. |
Supplemental European Search Report based on EP 08 87 7881 dated May 15, 2013. |
USPTO Office Action in U.S. Appl. No. 13/617,557 mailed Feb. 4, 2013. |
USPTO Office Action in U.S. Appl. No. 12/755,784 mailed Mar. 13, 2013. |
USPTO Office Action in U.S. Appl. No. 13/616,416 mailed Mar. 25, 2013. |
USPTO Office Action in U.S. Appl. No. 13/561,249 mailed Apr. 23, 2013. |
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed Apr. 26, 2013. |
USPTO Office Action in U.S. Appl. No. 13/088,916 mailed May 13, 2013. |
USPTO Office Action in U.S. Appl. No. 13/772,947 mailed Jun. 19, 2013. |
USPTO Office Action in U.S. Appl. No. 12/859,680 mailed Jul. 9, 2013. |
USPTO Office Action in U.S. Appl. No. 13/561,249 mailed Sep. 16, 2013. |
USPTO Office Action in U.S. Appl. No. 13/088,916 mailed Sep. 17, 2013. |
USPTO Office Action in U.S. Appl. No. 12/943,544 mailed Sep. 25, 2013. |
USPTO Office Action in U.S. Appl. No. 13/617,557 mailed Oct. 9, 2013. |
Extended European Search Report based on EP 10 76 2390 dated Oct. 30, 2013. |
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed Nov. 21, 2013. |
USPTO Office Action in U.S. Appl. No. 12/983,496 mailed Feb. 5, 2014. |
USPTO Office Action in U.S. Appl. No. 12/756,014 mailed Feb. 13, 2014. |
USPTO Office Action in U.S. Appl. No. 13/617,181 mailed Feb. 25, 2014. |
PCT International Search Report based on PCT/US13/076598 dated Mar. 19, 2014. |
USPTO Office Action in U.S. Appl. No. 13/655,808 mailed Mar. 27, 2014. |
USPTO Office Action in U.S. Appl. No. 13/553,247 mailed May 7, 2014. |
Extended European Search Report based on EP 14156473 dated May 13, 2014. |
USPTO Office Action in U.S. Appl. No. 13/800,518 mailed Jun. 10, 2014. |
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed Jun. 26, 2014. |
USPTO Office Action in U.S. Appl. No. 13/617,557 mailed Jun. 27, 2014. |
USPTO Office Action in U.S. Appl. No. 13/335,110 mailed Jul. 31, 2014. |
USPTO Office Action in U.S. Appl. No. 13/616,781 mailed Aug. 26, 2014. |
USPTO Office Action in U.S. Appl. No. 13/730,521 mailed Sep. 8, 2014. |
PCT International Search Report based on PCT/US13/049773 dated Oct. 1, 2013. |
USPTO Office Action in U.S. Appl. No. 12/756,014 mailed Oct. 7, 2014. |
USPTO Office Action in U.S. Appl. No. 13/553,450 mailed Oct. 24, 2014. |
USPTO Office Action in U.S. Appl. No. 13/335,110 mailed Oct. 24, 2014. |
USPTO Office Action in U.S. Appl. No. 13/553,247 mailed Dec. 5, 2014. |
USPTO Office Action in U.S. Appl. No. 13/553,051 mailed Dec. 23, 2014. |
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed Jan. 14, 2015. |
USPTO Office Action in U.S. Appl. No. 13/617,557 mailed Jan. 15, 2015. |
USPTO Office Action in U.S. Appl. No. 13/335,110 mailed Feb. 9, 2015. |
USPTO Office Action in U.S. Appl. No. 13/796,085 mailed Feb. 12, 2015. |
USPTO Office Action in U.S. Appl. No. 13/553,051 mailed Mar. 31, 2015. |
USPTO Office Action in U.S. Appl. No. 13/553,247 mailed May 1, 2015. |
USPTO Office Action in U.S. Appl. No. 13/297,097 mailed May 29, 2015. |
USPTO Office Action in U.S. Appl. No. 14/171,036 mailed Jun. 1, 2015. |
USPTO Office Action in U.S. Appl. No. 14/164,846 mailed Jun. 4, 2015. |
USPTO Office Action in U.S. Appl. No. 13/617,557 mailed Jul. 15, 2015. |
USPTO Office Action in U.S. Appl. No. 13/553,051 mailed Jan. 6, 2016. |
USPTO Office Action in U.S. Appl. No. 13/553,247 mailed Mar. 2, 2016. |
USPTO Office Action in U.S. Appl. No. 14/535,971 mailed Mar. 4, 2016. |
USPTO Office Action in U.S. Appl. No. 13/553,051 mailed Sep. 11, 2015. |
USPTO Office Action in U.S. Appl. No. 13/553,247 mailed Sep. 23, 2015. |
USPTO Office Action in U.S. Appl. No. 14/164,846 mailed Oct. 14, 2015. |
USPTO Office Action in U.S. Appl. No. 14/171,036 mailed Oct. 15, 2015. |
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed Oct. 22, 2015. |
USPTO Office Action in U.S. Appl. No. 13/617,557 mailed Jan. 14, 2016. |
USPTO Office Action in U.S. Appl. No. 14/177,748 mailed Jan. 25, 2016. |
USPTO Office Action in U.S. Appl. No. 14/535,913 mailed Feb. 22, 2016. |
U.S. Appl. No. 14/988,058, filed Jan. 5, 2016, Systems and Methods for Joint Stabilization. |
U.S. Appl. No. 14/996,275, filed Jan. 15, 2016, Apparatus for Delivery of Reinforcing Materials to Bone. |
USPTO Office Action in U.S. Appl. No. 14/535,913 mailed Sep. 26, 2016. |
USPTO Office Action in U.S. Appl. No. 13/553,247 mailed Oct. 13, 2016. |
USPTO Office Action in U.S. Appl. No. 14/996,275 mailed Nov. 14, 2016. |
International Search Report in PCT/US2016/60603 mailed Jan. 30, 2017. |
USPTO Office Action in U.S. Appl. No. 12/262,370 mailed Jun. 2, 2016. |
Number | Date | Country | |
---|---|---|---|
20140180288 A1 | Jun 2014 | US |
Number | Date | Country | |
---|---|---|---|
61739972 | Dec 2012 | US |